Pair Name | Glabridin, Paclitaxel | ||
Phytochemical Name | Glabridin (PubChem CID: 124052 ) | ||
Anticancer drug Name | Paclitaxel (PubChem CID: 36314 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Glabridin, Paclitaxel | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Inhibition-->Cell migration | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Up-regulation | Expression | CDH1 | hsa999 | |
Down-regulation | Expression | CYP2C8 | hsa1558 | |
Down-regulation | Expression | CYP2J2 | hsa1573 | |
Up-regulation | Expression | OCLN | hsa100506658 | |
Down-regulation | Expression | VIM | hsa7431 | |
Down-regulation | Expression | ZEB1 | hsa6935 | |
In Vitro Model | 4T1 | Malignant neoplasms of the mouse mammary gland | Mus musculus (Mouse) | CVCL_0125 |
In Vivo Model | The effect of glabridin on the pharmacokinetics of paclitaxel was assessed in healthy female Balb/C mice (25–30 g of body weight). | |||
Result | Glabridin plays dual action to intensify anti-metastatic potential of paclitaxel via impeding CYP2C8 in liver and CYP2J2/EETs in tumor of an orthotopic mouse model of breast cancer |
No. | Title | Href |
---|---|---|
1 | Glabridin plays dual action to intensify anti-metastatic potential of paclitaxel via impeding CYP2C8 in liver and CYP2J2/EETs in tumor of an orthotopic mouse model of breast cancer. Chem Biol Interact. 2023 Sep 1;382:110605. doi: 10.1016/j.cbi.2023.110605. | Click |